Does Moderna’s RSV vaccine lose efficacy faster than others?
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Our podcast this week centers exclusively on a tantalizing subject: Artificial intelligence in biotech. Give it a listen. Also, Moderna’s RSV vaccine efficacy seems lackluster compared to competitors, and the Bernie Sanders drug pricing song-and-dance did not seem to faze pharma CEOs.
Read Original Article: Does Moderna’s RSV vaccine lose efficacy faster than others? »
